Omeros Corporation

OMER ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $73.8M $111.8M $29.9M $64.8M $41.6M $13.5M $539.0K $1.6M
Cost of Revenue $902.0K $865.0K $512.0K $1.1M $1.4M $1.0M $0 $0
Gross Profit $72.9M $110.9M $29.4M $63.7M $40.2M $12.5M $539.0K $1.6M
Gross Margin 98.8% 99.2% 98.3% 98.3% 96.6% 92.3% 100.0% 100.0%
Operating Expenses
Research & Development $107.6M $106.3M $89.9M $55.6M $50.7M $48.4M $47.9M $36.3M
SG&A Expense $49.3M $39.7M $51.7M $52.0M $43.8M $35.3M $22.6M $15.8M
Operating Income $-156.9M $-146.0M $-112.2M $-43.9M $-54.3M $-71.2M $-70.0M $-50.5M
Operating Margin -212.6% -130.6% -375.7% -67.7% -130.4% -527.3% -12,988.5% -3,157.3%
Interest Expense $26.8M $22.7M $16.3M $11.0M $7.8M $3.6M $3.5M $2.4M
Pretax Income $-196.4M $-167.1M $-139.7M $-53.5M $-66.7M — — —
Income Tax Expense $-23.3M $-19.8M $-12.9M $0 $0 — — —
Net Income $-138.1M $-84.5M $-126.8M $-53.5M $-66.7M $-75.1M $-73.7M $-39.8M
Net Margin -187.0% -75.6% -424.4% -82.5% -160.4% -555.9% -13,668.5% -2,487.3%
EPS (Basic) $-2.41 $-1.71 $-2.61 $-1.17 $-1.65 $-2.00 $-2.22 $-1.39
EPS (Diluted) $-2.41 $-1.71 $-2.61 $-1.17 $-1.65 $-2.00 $-2.22 $-1.39
Shares Outstanding (Basic) 57.2M 49.5M 49.0M 48.2M 43.8M 38.0M 34.2M 30.4M
Shares Outstanding (Diluted) 57.2M 49.5M 49.0M 48.2M 43.8M 38.0M 34.2M 30.4M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →